Sanuwave Health EBITDA 1970-1969 | SNWV

Sanuwave Health ebitda from 1970 to 1969. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Sanuwave Health Annual EBITDA
(Millions of US $)
Sanuwave Health Quarterly EBITDA
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED PRODUCTS $0.179B $0.020B
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
Stock Name Country Market Cap PE Ratio
Primo Water (PRMB) United States $4.583B 36.19
P.A.M Transportation Services (PAMT) United States $0.414B 0.00
BioHarvest Sciences (BHST) Canada $0.099B 0.00
Alpha Cognition (ACOG) Canada $0.032B 0.00
Atlantic Coastal Acquisition II (ABP) United States $0.030B 0.00
Rigetti Computing (RGTI) United States $0.000B 0.00